1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Oxbridge Re Holdings entered an at-the-market sales agreement on June 22, 2026, with Chardan Capital Markets LLC, allowing it to sell ordinary shares through the agent over time. The deal replaces a prior agreement with Maxim Group LLC that was terminated on June 20, 2026, and sales are not required; shareholders could see dilution if shares are sold.
Shares with an aggregate offering price of up to $1,678,301 were registered under a Form S-3 shelf (File No. 333-287186).
Chardan will receive a commission of 3.0% of gross proceeds from any shares sold.
Net proceeds are intended for general corporate purposes, including funding reinsurance operations.
The company is not obligated to sell any shares under the agreement.
NeoGenomics completed a $316.25 million offering of 0.75% convertible senior notes due 2032, including an option exercised by the initial purchasers for $41.25 million. The company also used about $263.19 million to repurchase about $276.0 million of its 0.25% convertible notes due 2028, and it used about $28.7 million of offering proceeds for capped call transactions meant to reduce potential dilution.
Notes total $316.25 million, with interest of 0.75% per year payable semiannually, maturing July 1, 2032
Initial conversion price is about $14.16 per share, a 35.0% premium to the $10.49 closing price on June 16, 2026
Up to 30,147,733 shares may be issued on conversion; the company may settle conversions in cash, shares, or both
Concurrent repurchase of about $276.0 million of 2028 notes for about $263.19 million, including accrued interest
Rush Enterprises disclosed that its subsidiary Rush Truck Centres of Canada and the company, as guarantor, signed a Fourth Amendment with Bank of Montreal effective June 15, 2026. The amendment raises the total loan commitment on the Canadian floor plan credit agreement from $171.7 million CAD to $194.7 million CAD, a routine expansion of borrowing capacity that does not change the company's reported financial results.
Effective date of the Fourth Amendment: June 15, 2026
Total loan commitment increased from $171.7 million CAD to $194.7 million CAD
Counterparty is Bank of Montreal; the original agreement is dated July 15, 2022
On June 22, 2026, NextEra Energy Capital Holdings, a wholly-owned subsidiary of NextEra Energy, sold $3.75 billion in three series of junior subordinated debentures due 2056 and 2066. NEE guarantees the debentures on a subordinated basis, so the sale adds long-term subordinated debt backed by the parent.
Series AA: $1.0 billion due October 1, 2056, initial rate 6.000% through October 1, 2031
Series BB: $1.25 billion due October 1, 2056, initial rate 6.200% through October 1, 2036
Series CC: $1.5 billion due October 1, 2066, initial rate 6.625% through October 1, 2046
Debentures were registered under Securities Act registration statements and filed as exhibits with this 8-K; no earnings results were reported
Adaptive Biotechnologies issued $345 million of 0% convertible senior notes due 2031 on June 22, 2026, including an additional $45 million exercised by the initial purchasers. The company used $156.9 million of the net proceeds to repay its OrbiMed revenue interest purchase agreement, which ends its quarterly revenue-based payments to OrbiMed, and used part of the proceeds for a share repurchase and a capped call transaction.
Notes issued June 22, 2026: $345 million principal, including the $45 million option exercised June 17, 2026; net proceeds of about $334.5 million
$156.9 million used to repay all obligations under the OrbiMed Purchase Agreement, with the revenue interests terminated
Initial conversion price of about $24.11 per share, a 40.0% premium over the $17.22 closing price on June 16, 2026; notes mature July 1, 2031
About $25.0 million used to repurchase 1,451,800 shares of common stock in privately negotiated transactions
NorthWestern Energy Public Service Corporation, a wholly owned subsidiary of NorthWestern Energy Group, issued $150 million of South Dakota First Mortgage Bonds on June 15, 2026. The bonds carry a 5.51% interest rate and mature on June 15, 2036, and they rank equally with other debt secured by the same first mortgage lien. The filing describes a debt issuance under a standard mortgage indenture, with no change to the company's operations or outlook stated.
Principal amount: $150 million, issued June 15, 2026
Interest rate: 5.51%, maturing June 15, 2036
Terms set in the Twenty-third Supplemental Indenture dated June 1, 2026, with The Bank of New York Mellon as trustee
Bonds were sold in an exempt transaction and are not registered under the Securities Act of 1933
NutriBand Inc. entered into an amended three-year, $5,000,000 credit line on June 1, 2026, replacing a $5,000,000 facility from March 19, 2023 that was scheduled to expire July 13, 2026. The line is meant to fund the FDA approval process and commercial-scale manufacturing for its AVERSA Fentanyl product, and the filing states the lender cannot convert borrowings into common stock.
Three-year, $5,000,000 credit line entered June 1, 2026, replacing the March 19, 2023 facility
Drawdowns bear interest at 7% per annum
Lender cannot convert amounts outstanding under the line into common stock
Proceeds to support FDA approval and commercial-scale manufacturing of AVERSA Fentanyl
On June 18, 2026, United Natural Foods and its co-borrowers entered Amendment No. 5 to their Term Loan Agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment reduces the margin over SOFR on the approximately $371 million outstanding term loan from 4.75% to 4.00%, and all other material terms are unchanged. The change lowers the spread on the company's secured term debt, though the filing does not quantify any effect on interest expense.
Amendment No. 5 to the Term Loan Agreement dated October 22, 2018 was entered on June 18, 2026
Applicable margin over SOFR reduced from 4.75% to 4.00% on approximately $371 million outstanding
JPMorgan Chase Bank, N.A. serves as administrative and collateral agent
Full amendment to be filed as an exhibit to the Form 10-K for the year ended August 1, 2026
Ligand Pharmaceuticals announced a proposed private placement of $550 million in convertible senior notes due 2031, subject to market conditions, and amended its credit agreement to permit the notes and set new minimum Consolidated EBITDA levels. The company plans to use up to $75 million of net proceeds to repurchase common stock from certain note purchasers, and the interest rate and conversion terms will be set at pricing.
Proposed $550 million aggregate principal of convertible senior notes due September 15, 2031, offered privately to qualified institutional buyers; initial purchasers may buy up to an additional $82.5 million within a 13-day option period
Up to $75 million of net proceeds may be used to repurchase common stock from certain note purchasers in privately negotiated transactions
Fourth Amendment to the Credit Agreement sets minimum Consolidated EBITDA of $100 million for the four quarters ending June 30, 2026 through March 31, 2027, and $150 million for later periods
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.